Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
Core EBITDA Growth

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 59.64-14.83-17.6213.0223.10

What is the latest Core EBITDA Growth ratio of AUROBINDO PHARMA ?

The latest Core EBITDA Growth ratio of AUROBINDO PHARMA is 59.64 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202459.64
Mar2023-14.83
Mar2022-17.62
Mar202113.02
Mar202023.10

How is Core EBITDA Growth of AUROBINDO PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2024 59.64
Positive
Mar2023 -14.83
Negative
Mar2022 -17.62
Negative
Mar2021 13.02
-43.64
Mar2020 23.1 -

Other Financial Ratios of AUROBINDO PHARMA


Compare Core EBITDA Growth ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹67,082.4 Cr -0.5% -5.3% -8.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,768.0 Cr 0.4% -1.2% 12.2% Stock Analytics
DIVIS LABORATORIES ₹178,468.0 Cr 2.6% 8.4% 48.5% Stock Analytics
CIPLA ₹121,326.0 Cr -0.1% 0.5% 1.7% Stock Analytics
DR REDDYS LABORATORIES ₹113,757.0 Cr 3.2% 11.8% 11.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,345.0 Cr 3.4% 0.5% 12.8% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-0.5%

-5.3%

-8.3%

SENSEX

0.3%

0.7%

8.8%


You may also like the below Video Courses